Insider · CIK 0001236371
Gregory D Perry
Files at KALA (KALA BIO, Inc.), MRUS (Merus N.V.). First filing -, latest -.
Gregory D Perry files SEC Form 4 as director and CFO at KALA (KALA BIO, Inc.), and also at MRUS (Merus N.V.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Gregory D Perry has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | MRUS Merus N.V. | DDisposition to issuer Share Option (right to buy)derivative | -100,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | MRUS Merus N.V. | DDisposition to issuer Share Option (right to buy)derivative | -107,300 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | MRUS Merus N.V. | DDisposition to issuer Share Option (right to buy)derivative | -372,924 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | MRUS Merus N.V. | DDisposition to issuer Share Option (right to buy)derivative | -14,414 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | MRUS Merus N.V. | DDisposition to issuer Share Option (right to buy)derivative | -16,604 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | MRUS Merus N.V. | DDisposition to issuer Share Option (right to buy)derivative | -6,120 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | MRUS Merus N.V. | DDisposition to issuer Share Option (right to buy)derivative | -8,631 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | MRUS Merus N.V. | DDisposition to issuer Share Option (right to buy)derivative | -17,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | MRUS Merus N.V. | DDisposition to issuer Share Option (right to buy)derivative | -5,650 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | MRUS Merus N.V. | DDisposition to issuer Share Option (right to buy)derivative | -4,983 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | MRUS Merus N.V. | DDisposition to issuer Share Option (right to buy)derivative | -8,500 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Jun 15, 2025 | KALA KALA BIO, Inc. | AGrant or award Common Stock | +2,450 | $0.00 | $0 | 13,344 | Jun 17, 2025 |
| Jun 15, 2025 | KALA KALA BIO, Inc. | AGrant or award Stock Option (right to buy)derivative | +5,450 | $0.00 | $0 | 5,450 | Jun 17, 2025 |
Questions about Gregory D Perry
Answered from the filings on this page, as of the latest one.
Is Gregory D Perry buying or selling?
Gregory D Perry has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Gregory D Perry's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gregory D Perry has 0.
Where does Gregory D Perry file Form 4?
Gregory D Perry has filed Form 4 at KALA (KALA BIO, Inc.); MRUS (Merus N.V.) as Chief Financial Officer & PFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.